The stock of Clover Health Investments Corp. (NASDAQ:CLOV) last traded at $1.39, up 4.51% from the previous session.
Data from the available sources indicates that Clover Health Investments Corp. (NASDAQ:CLOV) is covered by 6 analysts. The consensus rating among analysts is ‘Hold’. As we calculate the median target price by taking the range between a high of $3.00 and a low of $0.75, we find $1.13. Given the previous closing price of $1.33, this indicates a potential downside of -15.04 percent. CLOV stock price is now 38.13% away from the 50-day moving average and 29.85% away from the 200-day moving average. The market capitalization of the company currently stands at $687.52M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
In total, 3 analysts have assigned it a hold rating, and 1 have given it a buy rating. Brokers who have rated the stock have averaged $1.46 as their price target over the next twelve months.
With the price target reduced from $7 to $3, Cowen Upgraded its rating from Underperform to Market Perform for Clover Health Investments Corp. (NASDAQ: CLOV).
Insiders disposed of 1,074,321 shares of company stock worth roughly $1.49 million over the past 1 year. A total of 3.10% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in CLOV stock. A new stake in Clover Health Investments Corp. shares was purchased by OLD MISSION CAPITAL, LLC during the first quarter worth $244,000. GRAHAM CAPITAL MANAGEMENT, L.P. invested $161,000 in shares of CLOV during the first quarter. In the first quarter, CAPTRUST FINANCIAL ADVISORS acquired a new stake in Clover Health Investments Corp. valued at approximately $56,000. BRAVE ASSET MANAGEMENT INC acquired a new stake in CLOV for approximately $42,000. TWO SIGMA ADVISERS, LP purchased a new stake in CLOV valued at around $42,000 in the second quarter. In total, there are 202 active investors with 32.50% ownership of the company’s stock.
With an opening price of $1.4700 on Wednesday morning, Clover Health Investments Corp. (NASDAQ: CLOV) set off the trading day. During the past 12 months, Clover Health Investments Corp. has had a low of $0.71 and a high of $3.50. As of last week, the company has a debt-to-equity ratio of 0.00, a current ratio of 1.10, and a quick ratio of 1.10. The fifty day moving average price for CLOV is $1.0151 and a two-hundred day moving average price translates $1.0703 for the stock.
The latest earnings results from Clover Health Investments Corp. (NASDAQ: CLOV) was released for Jun, 2023. According to the Healthcare Plans Company, earnings per share came in at -$0.06, beating analysts’ expectations of -$0.15 by 0.09. This compares to -$0.22 EPS in the same period last year. The net profit margin was -10.70% and return on equity was -89.70% for CLOV. The company reported revenue of $513.63 million for the quarter, compared to $846.7 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -39.34 percent. For the current quarter, analysts expect CLOV to generate $488.83M in revenue.
Clover Health Investments Corp.(CLOV) Company Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. The company was incorporated in 2014 and is based in Franklin, Tennessee.
